Multiple sclerosis

Multiple Sclerosis (MS) is a chronic, autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is characterized by the demyelination of nerve fibers, meaning the protective myelin sheath around the nerve fibers is damaged, leading to impaired nerve signal transmission. MS can lead to a wide range of neurological symptoms, which vary greatly among individuals depending on the location and extent of the damage.

A. Genetic Factors

  • Genetic predisposition: Although MS is not directly inherited, having a family member with the disease slightly increases the risk. Certain genes related to the immune system, particularly the human leukocyte antigen (HLA) gene, may increase susceptibility to MS.

B. Environmental Factors

  • Infections: Viral infections, particularly the Epstein-Barr virus (EBV), have been linked to an increased risk of MS. However, not everyone who has been infected with EBV will develop MS.
  • Geographic Location: MS is more common in regions further from the equator, where there is less sunlight and lower levels of vitamin D. This suggests that low vitamin D levels may play a role in MS development.
  • Smoking: Smoking has been associated with a higher risk of developing MS and may accelerate disease progression in those who already have it.

C. Immune System Dysfunction

MS is considered an autoimmune disease where the body's immune system mistakenly attacks its own tissue, particularly the myelin sheath that protects nerve fibers. This leads to inflammation, scarring (sclerosis), and eventual loss of nerve function.

    Related Conference of Multiple sclerosis

    February 03-04, 2025

    37th World Conference on Neurology

    London, UK
    February 17-18, 2025

    5th International Conference on Child Neurology

    Aix-en-Provence, France
    February 20-21, 2025

    6th International Conference on Neurologists

    Amsterdam, Netherlands
    February 24-25, 2025

    4th International Conference onAlzheimer and Dementia

    Madrid, Spain
    February 27-28, 2025

    7th World Depression Congress

    Paris, France
    March 10-11, 2025

    8th World Conference on Neuroscience

    Paris, France
    March 13-14, 2025

    7th World Conference on Neuroscience

    Prague, Czech Republic
    March 24-25, 2025

    38th European Neurology Congress 2025

    London, UK
    April 24-25, 2025

    6th World Congress on Sleep Disorders and Therapeutics

    Amsterdam, Netherlands
    April 29-30, 2025

    11th International Conference on Epilepsy & Treatment

    Barcelona, Spain
    May 12-13, 2025

    39th European Neurology Congress

    London, UK
    July 17-18, 2025

    31st Annual Summit on Neuroscience & Neurological Disorders

    Amsterdam, Netherlands
    July 23-24, 2025

    15th Global Alzheimers Summit

    Paris, France
    July 28-29, 2025

    35th World Congress on Neurology and Neuroscience

    Paris, France
    August 25-26, 2025

    20th Annual Congress on Neuroscience

    Aix-en-Provence, France
    September 25-26, 2025

    12th Annual congress on Stroke and Neurological Disorders

    Zurich, Switzerland
    October 20-21, 2025

    7th World Brain Congress

    Osaka, Japan
    October 29-30, 2025

    5th Annual Dementia Congress

    Amsterdam, Netherlands
    November 13-14, 2025

    38th International Conference on Neuroscience and Neurochemistry

    Aix-en-Provence, France

    Multiple sclerosis Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in